Adaptimmune

dusk parachute
Biotech

Novo Nordisk nominates CEO successor—Chutes & Ladders

Novo Nordisk nominates CEO successor. Adaptimmune execs out in strategic shuffle. Sage wipes board clean ahead of Supernus merger.
embryonic stem cells

Cell therapy biotech keeps adapting, selling 4 programs for $55M

Jul 28, 2025 10:52am
too many options

Adaptimmune questions own longevity, axes preclinical funding

Mar 20, 2025 2:04pm
mechanical gears shifting

Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

Nov 13, 2024 2:57pm
galapagos finch Darwin evolution

Galapagos selects Adaptimmune cell therapy in $665M collab

May 31, 2024 9:40am
unravel break rope tie fray fall apart thread string

Genentech axes $3B Adaptimmune cell therapy deal

Apr 12, 2024 11:22am